Cambridge Consultants Introduces Vortik Design For Liquid Spray Systems - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Cambridge Consultants Introduces Vortik Design For Liquid Spray Systems
Cyclonic-spray technology improves spray consistency and allows mixing at the point of delivery.

Equipment and Processing Report

Product development firm Cambridge Consultants introduced its Vortik technology that allows different liquids to be mixed at the point of spray without altering the spray characteristics. Pharmaceutical applications could include tablet coating and drug delivery outside of the respirable range (e.g., dermatological cream or nasal or buccal application).


Conventional atomizers use either high pressure or high airflow to create a spray. This new fluid handling technology combines low-pressure air and liquid in a specially shaped cyclone chamber. Shear between swirling air and the liquids creates the desired droplet size for spraying.

Allowing active ingredients to be mixed at the point of delivery overcomes shelf-life and stability issues. The technology provides consistent spray quality and tighter control of concentration and particle size.

Source: Cambridge Consultants

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
27%
Attracting a skilled workforce
30%
Obtaining/maintaining adequate financing
10%
Regulatory compliance
33%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: Equipment and Processing Report,
Click here